- Colorado Pharmacists Cautious About Providing Naloxone (pharmacytimes.com)
Naloxone expanded-access provisions that recently took effect in Colorado practically push pharmacists to provide the opioid overdose antidote to anyone requesting it, but many pharmacists in the state still have concerns about dispensing it...fear for some pharmacists...misconception that providing naloxone is encouraging drug abuse and facilitating dependence...
- Pharma’s Bright Future: Meet The Top 10 Drugs of 2020 (drugchannels.net)
latest edition of EvaluatePharma’s World Preview 2015, Outlook to 2020. This annual report projects for prescription drug sales and R&D activity in the U.S. and abroad…THINGS ARE GOING GREAT……AND THEY'RE ONLY GETTING BETTER..
- Pfizer’s revenue, profit beat as vaccine sales rise (newsdaily.com)
Pfizer….reported better-than-expected second-quarter profit and revenue, helped by strong demand for its pneumonia vaccine (Prevnar ) and new breast cancer drug (Ibrance), sending its shares up 1 percent…. global vaccines unit rose 44 percent to $1.58 billion… breast cancer drug ...generated $140 million in sales in its first full quarter on the market..
- New Findings from Midwestern University in the Area of Health and Medical Informatics Described (Towards creating the perfect electronic prescription) (pharmacychoice.com)
e-prescribing…full potential for improving the safety, effectiveness, and efficiency of prescription drug delivery, important work remains...ultimate goal…a clear, complete, and unambiguous e-prescription order that can be seamlessly received, processed, and fulfilled…without the need for additional clarification… new e-prescription transaction …NCPDP SCRIPT Standard…. move the industry closer to achieving this vision...
- Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge (bloomberg.com)
Gilead Sciences, maker of the hepatitis C drugs Sovaldi and Harvoni, posted second-quarter profit that topped analysts’ estimates as revenue surged. Gilead raised its sales forecast for the year.
- GAO IDs 3 ways DEA can improve communications with pharmacists, manufacturers (drugstorenews.com)PRESCRIPTION DRUGS More DEA Information about Registrants Controlled Substances Roles Could Improve Their Understanding and Help Ensure Access (gao.gov)
lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines, according to a report released by…Government Accountability Office…Both distributors and retail pharmacies still request improved guidance and a greater degree of interaction with the DEA, though the agency does not concur,…
- Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise (pharmacychoice.com)
Most employers have been using multi-tier prescription drug plans for many years, but new data…significant increase in the use of 4-tier plans, which typically cover the highest cost drugs, as well as major increases in corresponding median copays a trend that is expected to continue,..general competitive pressure will demand that employees contribute more for the highest tiers...
- Health Spending to Gobble Up More of U.S. Economy in Next Decade (bloomberg.com)
Spending on health care will take up an increasing proportion of the U.S. economy over the next decade as the population ages and more people gain insurance coverage under Obamacare,…Payments for hospitals, doctors, drugs and insurance will rise by about 5.8 percent a year through 2024, 1.1 percentage points faster than overall economic growth,...
- Drug maker tied to Vegas hepatitis outbreak to buy Allergan unit for $40.5B (reviewjournal.com)
Teva… linked to the 2008 hepatitis C outbreak in Las Vegas, has agreed to buy Allergan … generic drugs business… will turn (Teva ) into one of the world's largest pharmaceutical firms… In..2012, Teva… agreed to pay $285 million to settle…lawsuits arising from the hepatitis C outbreak tied to the Endoscopy Center of Southern Nevada.. Teva and Baxter Healthcare…were found liable..
- Moses Lake Professional Pharmacy Issues Voluntary Recall of Unexpired Sterile Human and Veterinary Compounded Drugs Due to Lack of Sterility Assurance (fda.gov)
Moses Lake Professional Pharmacy is voluntarily recalling human and veterinary sterile compounded drugs which are unexpired to the consumer level due to lack of sterility assurance….has not received any reports of product contamination or adverse events to date, and is issuing this voluntary recall out of an abundance of caution..




